Record Information |
---|
Version | 2.0 |
---|
Created at | 2024-01-29 16:01:13 UTC |
---|
Updated at | 2024-09-03 04:19:15 UTC |
---|
NP-MRD ID | NP0332444 |
---|
Natural Product DOI | https://doi.org/10.57994/1684 |
---|
Secondary Accession Numbers | None |
---|
Natural Product Identification |
---|
Common Name | OCT |
---|
Description | OCT belongs to the class of organic compounds known as taxanes and derivatives. These are diterpenoids with a structure based either on the taxane skeleton, or a derivative thereof. In term of phytochemistry, several derivatives of the taxane skeleton exist: 2(3->20)-Abeotaxane, 3,11-cyclotaxane, 11(15->1),11(10->9)-abeotaxane, 3,8-seco-taxane, and 11(15->1)-abeotaxane, among others. More complex skeletons have been found recently, which include the taxane-derived [3.3.3] Propellane ring system. OCT was first documented in 2024 (PMID: 39311975). Based on a literature review a significant number of articles have been published on OCT (PMID: 39311976) (PMID: 39311802) (PMID: 39311664) (PMID: 39311317) (PMID: 39310639) (PMID: 39310537). |
---|
Structure | [H][C@]12CC34C(C)[C@@H]5CC[C@@]3(C)CCC4(C1(C)C)[C@](C)(CC2)O5 InChI=1S/C20H32O/c1-13-15-7-8-17(4)10-11-20-16(2,3)14(12-19(13,17)20)6-9-18(20,5)21-15/h13-15H,6-12H2,1-5H3/t13?,14-,15-,17-,18-,19?,20?/m0/s1 |
---|
Synonyms | Not Available |
---|
Chemical Formula | C20H32O |
---|
Average Mass | 288.4750 Da |
---|
Monoisotopic Mass | 288.24532 Da |
---|
IUPAC Name | (5R,8S,10S,13S)-5,10,15,16,16-pentamethyl-9-oxapentacyclo[6.6.1.1^{2,13}.0^{1,5}.0^{2,10}]hexadecane |
---|
Traditional Name | (5R,8S,10S,13S)-5,10,15,16,16-pentamethyl-9-oxapentacyclo[6.6.1.1^{2,13}.0^{1,5}.0^{2,10}]hexadecane |
---|
CAS Registry Number | Not Available |
---|
SMILES | [H][C@]12CC34C(C)[C@@H]5CC[C@@]3(C)CCC4(C1(C)C)[C@](C)(CC2)O5 |
---|
InChI Identifier | InChI=1S/C20H32O/c1-13-15-7-8-17(4)10-11-20-16(2,3)14(12-19(13,17)20)6-9-18(20,5)21-15/h13-15H,6-12H2,1-5H3/t13?,14-,15-,17-,18-,19?,20?/m0/s1 |
---|
InChI Key | PXOKLVAZSTVVAE-HOXJIZQNSA-N |
---|
Experimental Spectra |
---|
|
| Spectrum Type | Description | Depositor Email | Depositor Organization | Depositor | Deposition Date | View |
---|
1D NMR | 1H NMR Spectrum (1D, 500 MHz, CDCL3, experimental) | ctliu@stanford.edu | Stanford | Jack Liu | 2024-01-29 | View Spectrum |
| Predicted Spectra |
---|
|
| Not Available | Chemical Shift Submissions |
---|
|
| Not Available | Species |
---|
Species of Origin | Not Available |
---|
Chemical Taxonomy |
---|
Description | This compound belongs to the class of organic compounds known as taxanes and derivatives. These are diterpenoids with a structure based either on the taxane skeleton, or a derivative thereof. In term of phytochemistry, several derivatives of the taxane skeleton exist: 2(3->20)-Abeotaxane, 3,11-cyclotaxane, 11(15->1),11(10->9)-abeotaxane, 3,8-seco-taxane, and 11(15->1)-abeotaxane, among others. More complex skeletons have been found recently, which include the taxane-derived [3.3.3] Propellane ring system. |
---|
Kingdom | Organic compounds |
---|
Super Class | Lipids and lipid-like molecules |
---|
Class | Prenol lipids |
---|
Sub Class | Diterpenoids |
---|
Direct Parent | Taxanes and derivatives |
---|
Alternative Parents | |
---|
Substituents | - 3,11-cyclotaxane diterpenoid
- 8,9-secoeremophilane skeleton
- Secoiridoid-skeleton
- Oxane
- Oxacycle
- Organoheterocyclic compound
- Ether
- Dialkyl ether
- Organic oxygen compound
- Hydrocarbon derivative
- Organooxygen compound
- Aliphatic heteropolycyclic compound
|
---|
Molecular Framework | Aliphatic heteropolycyclic compounds |
---|
External Descriptors | Not Available |
---|
Physical Properties |
---|
State | Not Available |
---|
Experimental Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Predicted Properties | |
---|
General References | - Proenca H, Antunes M, Ferreira JT, Magro P, Faria M, Marques-Neves C: Outcomes of amniotic membrane transplant for refractory macular hole - an optical coherence tomography and autofluorescence long-term study. Graefes Arch Clin Exp Ophthalmol. 2024 Sep 23. doi: 10.1007/s00417-024-06609-4. [PubMed:39311975 ]
- Agarwal A, Banerjee M, Azad SV, Chawla R, Vohra R, Venkatesh P, Kumar V: Evaluation of peripheral retinal degenerations using ultra-widefield swept source optical coherence tomography. Graefes Arch Clin Exp Ophthalmol. 2024 Sep 23. doi: 10.1007/s00417-024-06593-9. [PubMed:39311976 ]
- Xie Y, Sun Y, Shao Y, Tian J, Fu Y, Yang D, Yang Y, Cao K, Zhang Y, Wang H, Wang G, Wang N: Impact of Acute Short-term Hypobaric Hypoxia on Anterior Chamber Geometry. J Glaucoma. 2024 Sep 24. doi: 10.1097/IJG.0000000000002498. [PubMed:39311802 ]
- Lemire D, Dumas T, Guillaumont D, Solari PL, Menut D, Giusti F, Arrachart G, Dourdain S, Pellet-Rostaing S: Molecular and Supramolecular Study of Uranium/Plutonium Liquid-Liquid Extraction with N,N-Dialkylamides. Inorg Chem. 2024 Sep 23. doi: 10.1021/acs.inorgchem.4c02880. [PubMed:39311664 ]
- McNeely RN, McGinnity K, Stewart S, Pazo EE, Moutari S, Moore JE: A Multi Comparison of 8 Different Intraocular Lens Biometry Formulae, Including a Machine Learning Thin Lens Formula (MM) and an Inbuilt Anterior Segment Optical Coherence Tomography Ray Tracing Formula. Vision (Basel). 2024 Aug 28;8(3):49. doi: 10.3390/vision8030049. [PubMed:39311317 ]
- Abbas MA, Al-Wassit AS, Ismail M: The Effect of Pan-Retinal Photocoagulation on Central Macular Thickness in a Sample of Iraqi Patients With Proliferative Diabetic Retinopathy. Cureus. 2024 Aug 23;16(8):e67616. doi: 10.7759/cureus.67616. eCollection 2024 Aug. [PubMed:39310639 ]
- Agrawal T, More P, Paranjpe R, Vatkar V, Potdar PP: Dystrophia Adiposa Corneae: An Out-of-the-Box Diagnosis. Cureus. 2024 Aug 23;16(8):e67580. doi: 10.7759/cureus.67580. eCollection 2024 Aug. [PubMed:39310537 ]
- Kim JW, Wei S, Zhang P, Gehlbach P, Kang JU, Iordachita I, Kobilarov M: Towards Autonomous Retinal Microsurgery Using RGB-D Images. IEEE Robot Autom Lett. 2024 Apr;9(4):3807-3814. doi: 10.1109/lra.2024.3368192. Epub 2024 Feb 21. [PubMed:39309968 ]
- Pandey AK, Rout A, Gampa P, Khan MA, Singh AK, Chauhan R: A spectral domain optical coherence tomography (SD-OCT) study of intraretinal hyperreflective foci and its relationship with visual acuity and grades of retinopathy among patients of diabetes mellitus in Indian population. Med J Armed Forces India. 2024 Sep-Oct;80(5):572-577. doi: 10.1016/j.mjafi.2024.04.019. Epub 2024 Jul 3. [PubMed:39309581 ]
- Walha Y, Rekik M, Moalla KS, Kammoun S, Ayadi O, Mhiri C, Dammak M, Trigui A: Evaluation of nerve fiber layer and ganglion cell complex changes in patients with migraine using optical coherence tomography. eNeurologicalSci. 2024 Sep 4;37:100525. doi: 10.1016/j.ensci.2024.100525. eCollection 2024 Dec. [PubMed:39309450 ]
- Chatzistergiou V, Lejoyeux R, Bonnin S, Tadayoni R: Prevalence of Fovea Plana in patients with rhegmatogenous retinal detachment. Eur J Ophthalmol. 2024 Sep 23:11206721241286125. doi: 10.1177/11206721241286125. [PubMed:39308451 ]
- Seiger K, Driscoll W, Messele F, Golbari NM, Fan X, Holmes J, Zachary CB: Use of Optical Coherence Tomography to Assess Properties of Cutaneous Defects Following Radiofrequency Microneedling and Laser Treatment. Lasers Surg Med. 2024 Nov;56(9):762-769. doi: 10.1002/lsm.23840. Epub 2024 Sep 22. [PubMed:39308122 ]
- Kanzaki Y, Ueki Y, Sunohara D, Okina Y, Nomi H, Machida K, Kashiwagi D, Yoda H, Maruyama S, Nagae A, Kato T, Saigusa T, Dijkstra J, Ebisawa S, Kuwahara K: Impact of multiple ballooning on coronary lesions as assessed by optical coherence tomography and intravascular ultrasound. Catheter Cardiovasc Interv. 2024 Sep 22. doi: 10.1002/ccd.31239. [PubMed:39308073 ]
- Chen X, Guo S, Wang JM, Li J, Ni L, Kang HJ, Qian DW, Duan JA: [Comparison on effects of Lycii Fructus from different origins on NaIO_3-induced retinal degenerative diseases in mice by multivariate statistical analysis]. Zhongguo Zhong Yao Za Zhi. 2024 Aug;49(16):4521-4531. doi: 10.19540/j.cnki.cjcmm.20240414.103. [PubMed:39307788 ]
- Montalban X, Vermersch P, Arnold DL, Bar-Or A, Cree BAC, Cross AH, Kubala Havrdova E, Kappos L, Stuve O, Wiendl H, Wolinsky JS, Dahlke F, Le Bolay C, Shen Loo L, Gopalakrishnan S, Hyvert Y, Javor A, Guehring H, Tenenbaum N, Tomic D: Safety and efficacy of evobrutinib in relapsing multiple sclerosis (evolutionRMS1 and evolutionRMS2): two multicentre, randomised, double-blind, active-controlled, phase 3 trials. Lancet Neurol. 2024 Sep 19:S1474-4422(24)00328-4. doi: 10.1016/S1474-4422(24)00328-4. [PubMed:39307151 ]
|
---|